Automatic Dependent Surveillance Broadcast Research 2024: Global Trends, Forecasts and Competitive Analysis to 2030 Featuring Honeywell, L3, Esterline, Garmin, Rockwell Collins, Indra Sistemas, Harris
July 23, 2024 09:34 ET
|
Research and Markets
Dublin, July 23, 2024 (GLOBE NEWSWIRE) -- The "Automatic Dependent Surveillance Broadcast Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...
Shirofune Releases Expanded Improvement Suggestion Feature for Amazon Ads
July 22, 2024 08:00 ET
|
Shirofune
EL SEGUNDO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Shirofune, the leading digital advertising automation management tool, today announced an enhanced Improvement Suggestion feature that proposes...
Mobilicom Announces Receipt of Nasdaq Minimum Bid Price Notification
June 28, 2024 16:15 ET
|
Mobilicom Limited
Shoham, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) ("Mobilicom" or the "Company"), a provider of cybersecurity and robust solutions for drones and robotics,...
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 07, 2024 08:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Evaxion Announces Closing of $15 Million Public Offering
February 06, 2024 08:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Semcasting Launches Real-Time Voter Measurement Feature in AudienceDesigner for Political Advertisers
February 05, 2024 09:00 ET
|
Semcasting
Semcasting launches Real-Time Voter Measurement (RTVM), a new voter transparency feature in AudienceDesigner (ADS)
Evaxion Biotech Announces Pricing of $15 Million Public Offering
February 01, 2024 09:20 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Evaxion Announces Completion of ADS Ratio Change
January 22, 2024 16:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Evaxion Announces Plan to Implement ADS Ratio Change
January 08, 2024 08:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Global Automatic Dependent Surveillance Broadcast (ADS-B) Strategic Analysis Report 2023: Market to Reach $2.8 Billion by 2030 - Sustained Emphasis on Improving Aircraft Safety
December 04, 2023 09:18 ET
|
Research and Markets
Dublin, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The "Automatic Dependent Surveillance Broadcast (ADS-B) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...